News
The stock market experienced quite a bit of volatility during President Donald Trump's first 100 days in office.
Some of it is in the new Boston home of Eli Lilly & Co ., a $700 million research and development facility along Fort Point ...
Though Eli Lilly and Novo Nordisk have recently taken steps to make their uber-popular GLP-1 drugs more affordable for ...
The second home sits just north of where Eli Lilly is setting up shop in the LEAP District. Property records show the IEDC ...
GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...
The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the ...
Explore more
Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...
During a live event, Shuo Ma, MD, PhD, discussed the resistance mutation analysis of patients who had disease progression ...
Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...
Hospital nurses immediately diagnosed Kelly with type 1 diabetes, a non-communicable disease (NCD), and put her on a treatment regimen that she will likely need to follow for the rest of her life.
“The legacy I hope to build is one of freedom—freedom from anything that’s keeping you from becoming who you truly want to be in this life. I see so many people stuck in jobs they hate, or just living ...
A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results